Paid Clinical Trials in Uniontown, PA
As of August 2026, 32 paid clinical trials are recruiting in Uniontown, Pennsylvania. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Uniontown offers studies at sites including UPMC Cancer Center-Uniontown for conditions such as Obesity, Overweight, Crohn's Disease, Diabetes Mellitus, Type 2. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Uniontown
Trials by drug in Uniontown
Filter results
Newly added in Uniontown
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
31 clinical trials
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Top Research Study Locations in Uniontown
Researchers run research studies in Uniontown, PA at 12 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| UPMC Cancer Center-Uniontown | Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Advanced Esophageal Adenocarcinoma | 14 |
| Preferred Primary Care Physicians | Obesity, Overweight, Body Weight | 5 |
| UPMC Uniontown Hospital Radiation Oncology | Biochemically Recurrent Prostate Carcinoma, Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma | 3 |
| Frontier Clinical Re search, LLC | Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis | 2 |
| Frontier Clinical Research | C. Diff Infection, C.Difficile Diarrhea, CDI | 2 |
| Preferred Primary Care Physicians, Inc. | Body Weight, Diabetes Mellitus, Type 2, Nutrition Disorders | 2 |
| Frontier Clinical Research - Uniontown | Colitis Ulcerative, Crohn's Disease | 2 |
| Frontier Clinical Research, LLC | Moderately to Severely Active Crohn Disease, Crohn's Disease | 2 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| GSK Investigational Site | Irritable Bowel Syndrome | 1 |
| Preferred Primary Care Physicians - Matthew Drive | Type 2 Diabetes | 1 |
| Preferred Primary Care Physicians-Uniontown-69137 | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 1 |
Active & Upcoming Studies in Uniontown (2026)
Recruiting trials in Uniontown grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (14 active studies)
- A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer · Phase 3 · National Cancer Institute (NCI)
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab · Phase 3 · Alliance for Clinical Trials in Oncology
Diabetes & metabolic (6 active studies)
- A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar · Phase 3 · Boehringer Ingelheim
- A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes · Phase 2 · Novo Nordisk A/S
Vaccines (2 active studies)
- A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine · Phase 3 · Pfizer
- A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease · Phase 3 · Pfizer
Cardiovascular (2 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
Common conditions studied in Uniontown
- Obesity (3 active studies)
- Overweight (3 active studies)
- Crohn's Disease (2 active studies)
- Diabetes Mellitus, Type 2 (2 active studies)
- Hypertension (2 active studies)
- Recurrent Lung Non-Small Cell Carcinoma (2 active studies)
Leading research sponsors in Uniontown
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Pfizer
- Alliance for Clinical Trials in Oncology
- Boehringer Ingelheim
Frequently asked questions
How many paid clinical trials are currently recruiting in Uniontown?
There are approximately 32 recruiting clinical trials in Uniontown, Pennsylvania listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Uniontown pay participants?
Most recruiting trials in Uniontown compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Uniontown?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Uniontown?
The most common conditions under active study in Uniontown include Obesity (3), Overweight (3), Crohn's Disease (2), Diabetes Mellitus, Type 2 (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Uniontown?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Uniontown on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Uniontown?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Uniontown?
Recruiting research sites in Uniontown include UPMC Cancer Center-Uniontown, Preferred Primary Care Physicians, UPMC Uniontown Hospital Radiation Oncology, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Uniontown right now?
The largest active categories in Uniontown are Cancer & tumors (14), Diabetes & metabolic (6), Vaccines (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.